These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20026603)

  • 1. Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.
    Catalano S; Malivindi R; Giordano C; Gu G; Panza S; Bonofiglio D; Lanzino M; Sisci D; Panno ML; Andò S
    J Biol Chem; 2010 Feb; 285(8):5581-93. PubMed ID: 20026603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
    Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
    Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
    Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
    Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A steroidogenic factor-1-binding site and cyclic adenosine 3',5'-monophosphate response element-like elements are required for the activity of the rat aromatase promoter in rat Leydig tumor cell lines.
    Young M; McPhaul MJ
    Endocrinology; 1998 Dec; 139(12):5082-93. PubMed ID: 9832447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression.
    Giordano C; Catalano S; Panza S; Vizza D; Barone I; Bonofiglio D; Gelsomino L; Rizza P; Fuqua SA; Andò S
    Oncogene; 2011 Sep; 30(39):4129-40. PubMed ID: 21499302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1.
    Hoeke MO; Heegsma J; Hoekstra M; Moshage H; Faber KN
    PLoS One; 2014; 9(2):e88011. PubMed ID: 24498423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization and regulation of aromatase liver receptor homologue-1 in the developing rat testis.
    Sierens J; Jakody I; Poobalan Y; Meachem SJ; Knower K; Young MJ; Sirianni R; Pezzi V; Clyne CD
    Mol Cell Endocrinol; 2010 Jul; 323(2):307-13. PubMed ID: 20214950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development.
    Maris P; Campana A; Barone I; Giordano C; Morelli C; Malivindi R; Sisci D; Aquila S; Rago V; Bonofiglio D; Catalano S; Lanzino M; Andò S
    Endocrinology; 2015 Apr; 156(4):1251-62. PubMed ID: 25603045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesoid X Receptor Agonist GW4064 Inhibits Aromatase and ERβ Expression in Human Endometriotic Stromal Cells.
    Wu PL; Zeng C; Zhou YF; Yin L; Yu XL; Xue Q
    Reprod Sci; 2019 Aug; 26(8):1111-1120. PubMed ID: 30428773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroidogenic factor 1, an orphan nuclear receptor, regulates the expression of the rat aromatase gene in gonadal tissues.
    Lynch JP; Lala DS; Peluso JJ; Luo W; Parker KL; White BA
    Mol Endocrinol; 1993 Jun; 7(6):776-86. PubMed ID: 8395654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice.
    Li L; Liu H; Peng J; Wang Y; Zhang Y; Dong J; Liu X; Guo D; Jiang Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):880-5. PubMed ID: 24211198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human class I alcohol dehydrogenases by bile acids.
    Langhi C; Pedraz-Cuesta E; Haro D; Marrero PF; Rodríguez JC
    J Lipid Res; 2013 Sep; 54(9):2475-84. PubMed ID: 23772048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
    Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.
    Swales KE; Korbonits M; Carpenter R; Walsh DT; Warner TD; Bishop-Bailey D
    Cancer Res; 2006 Oct; 66(20):10120-6. PubMed ID: 17047076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients.
    Journe F; Durbecq V; Chaboteaux C; Rouas G; Laurent G; Nonclercq D; Sotiriou C; Body JJ; Larsimont D
    Breast Cancer Res Treat; 2009 Jun; 115(3):523-35. PubMed ID: 18563553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cells.
    Sirianni R; Chimento A; De Luca A; Zolea F; Carpino A; Rago V; Maggiolini M; Andò S; Pezzi V
    J Biol Chem; 2009 Oct; 284(42):28905-16. PubMed ID: 19679653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triiodothyronine decreases the activity of the proximal promoter (PII) of the aromatase gene in the mouse Sertoli cell line, TM4.
    Catalano S; Pezzi V; Chimento A; Giordano C; Carpino A; Young M; McPhaul MJ; Andò S
    Mol Endocrinol; 2003 May; 17(5):923-34. PubMed ID: 12586841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1α binding to HNF4α.
    Wang S; Yuan X; Lu D; Guo L; Wu B
    Biochem Pharmacol; 2017 Dec; 145():202-209. PubMed ID: 28912067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.